Skip to main navigation Skip to search Skip to main content

Substantiating the concerns about recombinant human activated protein C use in sepsis

  • Katherine J. Deans
  • , Peter C. Minneci
  • , Steven M. Banks
  • , Charles Natanson
  • , Peter Q. Eichacker

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)2542-2543
Number of pages2
JournalCritical Care Medicine
Volume32
Issue number12
DOIs
StatePublished - Dec 2004

Keywords

  • Activated protein C
  • Clinical practice
  • Corticosteroids
  • Drotrecogin alfa
  • Mortality
  • PROWESS
  • Recombinant human activated protein C

Cite this